<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML xmlns="http://www.w3.org/TR/REC-html40" xmlns:v =
"urn:schemas-microsoft-com:vml" xmlns:o =
"urn:schemas-microsoft-com:office:office" xmlns:w =
"urn:schemas-microsoft-com:office:word" xmlns:m =
"http://schemas.microsoft.com/office/2004/12/omml"><HEAD>
<META content="text/html; charset=iso-8859-1" http-equiv=Content-Type>
<META name=GENERATOR content="MSHTML 8.00.6001.19328">
<STYLE>@font-face {
font-family: Courier;
}
@font-face {
font-family: Cambria Math;
}
@font-face {
font-family: Calibri;
}
@font-face {
font-family: Tahoma;
}
@font-face {
font-family: Webdings;
}
@font-face {
font-family: Consolas;
}
@page WordSection1 {size: 8.5in 11.0in; margin: 1.0in 1.0in 1.0in 1.0in; }
P.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
LI.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
DIV.MsoNormal {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt
}
H1 {
FONT-FAMILY: "Times New Roman","serif"; MARGIN-LEFT: 0in; FONT-SIZE: 24pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0in; mso-style-priority: 9; mso-style-link: "Heading 1 Char"; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto
}
H6 {
FONT-FAMILY: "Times New Roman","serif"; MARGIN-LEFT: 0in; FONT-SIZE: 7.5pt; FONT-WEIGHT: bold; MARGIN-RIGHT: 0in; mso-style-priority: 9; mso-style-link: "Heading 6 Char"; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto
}
A:link {
COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlink {
COLOR: blue; TEXT-DECORATION: underline; mso-style-priority: 99
}
A:visited {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
SPAN.MsoHyperlinkFollowed {
COLOR: purple; TEXT-DECORATION: underline; mso-style-priority: 99
}
P.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
LI.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
DIV.MsoPlainText {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Calibri","sans-serif"; FONT-SIZE: 11pt; mso-style-priority: 99; mso-style-link: "Plain Text Char"
}
P {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; mso-style-priority: 99
}
P.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
LI.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
DIV.MsoAcetate {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Tahoma","sans-serif"; FONT-SIZE: 8pt; mso-style-priority: 99; mso-style-link: "Balloon Text Char"
}
SPAN.Heading1Char {
FONT-FAMILY: "Cambria","serif"; COLOR: #365f91; FONT-WEIGHT: bold; mso-style-priority: 9; mso-style-link: "Heading 1"; mso-style-name: "Heading 1 Char"
}
SPAN.Heading6Char {
FONT-STYLE: italic; FONT-FAMILY: "Cambria","serif"; COLOR: #243f60; mso-style-priority: 9; mso-style-link: "Heading 6"; mso-style-name: "Heading 6 Char"
}
SPAN.PlainTextChar {
FONT-FAMILY: Consolas; mso-style-priority: 99; mso-style-link: "Plain Text"; mso-style-name: "Plain Text Char"
}
SPAN.BalloonTextChar {
FONT-FAMILY: "Tahoma","sans-serif"; mso-style-priority: 99; mso-style-link: "Balloon Text"; mso-style-name: "Balloon Text Char"
}
P.caption {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; mso-style-name: caption
}
LI.caption {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; mso-style-name: caption
}
DIV.caption {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 12pt; mso-style-name: caption
}
P.msochpdefault {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 10pt; mso-style-name: msochpdefault
}
LI.msochpdefault {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 10pt; mso-style-name: msochpdefault
}
DIV.msochpdefault {
MARGIN: 0in 0in 0pt; FONT-FAMILY: "Times New Roman","serif"; FONT-SIZE: 10pt; mso-style-name: msochpdefault
}
SPAN.heading1char0 {
FONT-FAMILY: "Times New Roman","serif"; FONT-WEIGHT: bold; mso-style-name: heading1char
}
SPAN.heading6char0 {
FONT-FAMILY: "Times New Roman","serif"; FONT-WEIGHT: bold; mso-style-name: heading6char
}
SPAN.plaintextchar0 {
FONT-FAMILY: "Calibri","sans-serif"; mso-style-name: plaintextchar
}
SPAN.balloontextchar0 {
FONT-FAMILY: "Tahoma","sans-serif"; mso-style-name: balloontextchar
}
SPAN.emailstyle25 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: windowtext; mso-style-name: emailstyle25
}
SPAN.emailstyle27 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: #1f497d; mso-style-name: emailstyle27
}
SPAN.emailstyle28 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: #1f497d; mso-style-name: emailstyle28
}
SPAN.EmailStyle33 {
FONT-FAMILY: "Calibri","sans-serif"; COLOR: #1f497d; mso-style-type: personal-reply
}
.msochpdefault {
FONT-SIZE: 10pt; mso-style-type: export-only
}
DIV.WordSection1 {
page: WordSection1
}
</STYLE>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></HEAD>
<BODY lang=EN-US link=blue bgColor=#ffffff vLink=purple>
<DIV>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times">FYI</SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times">The California
Medical Assoc adopted the following resolution at their recent annual meeting..
It is also being referred to the AMA for national action.</SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times"><FONT
face=Calibri>RESOLVED: That CMA support medication collection or “take back”
programs, funded in whole or part by the pharmaceutical industry, that help keep
unused medications out of the environment and out of the hands of potential
overdose victims or drug abusers; and be it further<BR><SPAN
style="FONT-FAMILY: Times"></SPAN><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT></FONT></P>
<P style="MARGIN: 0.1pt 0in" class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times">RESOLVED, that this be referred for national
action.</SPAN></FONT></P>
<P class=MsoNormal><FONT size=2 face=Arial></FONT><BR></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times">Ted
Schettler</SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><B><SPAN
style="FONT-FAMILY: Times"></SPAN></B></FONT> </P>
<P class=MsoNormal><FONT size=+0><B><SPAN style="FONT-FAMILY: Times">UNUSED
MEDICATION COLLECTION/"TAKE BACK” PROGRAMS </SPAN></B><B><SPAN
style="FONT-FAMILY: Times"><BR></SPAN></B><B><SPAN
style="FONT-FAMILY: Times">Author: Stephen Follansbee, MD, Steve Heilig,
MPH</SPAN></B><B><SPAN style="FONT-FAMILY: Times"> </SPAN></B><SPAN
style="FONT-FAMILY: Times"></SPAN><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times">Adopted as
</SPAN><SPAN style="FONT-FAMILY: Times">Resolution 104-2012, California Medical
Association)</SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"> </SPAN><B><SPAN style="FONT-FAMILY: Times">
</SPAN></B></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times">Whereas,
Discarded medications often end up in waterways, landfills, and other locations
where they can be the source of accidental overdoses, resale for abuse, or
</SPAN><SPAN style="FONT-FAMILY: sans-serif">become</SPAN><SPAN
style="FONT-FAMILY: Times"> pollutants which can be ingested or otherwise effect
humans and other creatures; and </SPAN><SPAN
style="FONT-FAMILY: Times"><BR></SPAN><SPAN
style="FONT-FAMILY: Times"> </SPAN><SPAN style="FONT-FAMILY: Times">
<BR></SPAN><SPAN style="FONT-FAMILY: Times">Whereas, </SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'">British Columbia </SPAN><SPAN
style="FONT-FAMILY: Times">has a medication collection system designed to make
it easier for residents to get rid of their unwanted prescription medications
and help prevent overdoses and accidental poisonings and reduce water pollution;
and</SPAN><SPAN style="FONT-FAMILY: Times"> </SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times"></SPAN><SPAN
style="FONT-FAMILY: Times"><BR></SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'">Whereas, in California, Alameda County
Supervisors recently unanimously approved a nationally unprecedented Safe Drug
Disposal Ordinance requiring producers of drugs sold or distributed in the
county to pay for the safe collection and disposal of unused medications;
failure to comply will cost drugmakers $1,000 a day in fines;
and</SPAN><SPAN style="FONT-FAMILY: Times"> <BR></SPAN><SPAN
style="FONT-FAMILY: Times"> </SPAN><SPAN style="FONT-FAMILY: Times">
</SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: 'Times New Roman'">Whereas, existing medication collection
programs costs are largely borne by public entities, hospitals, </SPAN><SPAN
style="FONT-FAMILY: sans-serif">citizens directly if they contact their local
refuse disposal company for special collection, </SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'">and law enforcement, but the Alameda
program shifts the cost of disposal from taxpayers to drug companies. Currently
</SPAN><SPAN style="FONT-FAMILY: sans-serif">in</SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'"> Alameda County, residents can discard
pills they no longer need at 28 publicly funded drop-off locations, which
cost</SPAN><SPAN style="FONT-FAMILY: sans-serif">s</SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'"> an estimated $330,000 </SPAN><SPAN
style="FONT-FAMILY: sans-serif">annually </SPAN><SPAN
style="FONT-FAMILY: 'Times New Roman'">in public funds; now be
it</SPAN><SPAN style="FONT-FAMILY: Times"> <BR></SPAN><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT></P>
<P class=MsoNormal><FONT size=+0><BR>RESOLVED: That CMA support medication
collection or “take back” programs, funded in whole or part by the
pharmaceutical industry, that help keep unused medications out of the
environment and out of the hands of potential overdose victims or drug abusers;
and be it further<BR><SPAN style="FONT-FAMILY: Times"></SPAN></FONT><FONT
size=+0><SPAN style="FONT-FAMILY: Times"></SPAN></FONT></P>
<P style="MARGIN: 0.1pt 0in" class=MsoNormal><FONT size=+0><SPAN
style="FONT-FAMILY: Times"></SPAN></FONT> </P>
<P class=MsoNormal><FONT size=+0><SPAN style="FONT-FAMILY: Times">RESOLVED, that
this be referred for national action.</SPAN></FONT></P><BR><BR></DIV>
<BLOCKQUOTE
style="BORDER-LEFT: #000000 2px solid; PADDING-LEFT: 5px; PADDING-RIGHT: 0px; MARGIN-LEFT: 5px; MARGIN-RIGHT: 0px">
<DIV style="FONT: 10pt arial">----- Original Message ----- </DIV>
<DIV
style="FONT: 10pt arial; BACKGROUND: #e4e4e4; font-color: black"><B>From:</B>
<A title=scott@productstewardship.us
href="mailto:scott@productstewardship.us">Scott Cassel</A> </DIV>
<DIV style="FONT: 10pt arial"><B>To:</B> <A
title=pharmwaste@lists.dep.state.fl.us
href="mailto:pharmwaste@lists.dep.state.fl.us">pharmwaste@lists.dep.state.fl.us</A>
</DIV>
<DIV style="FONT: 10pt arial"><B>Sent:</B> Sunday, December 09, 2012 4:08
AM</DIV>
<DIV style="FONT: 10pt arial"><B>Subject:</B> [Pharmwaste] Pharma industry
complaint against Alameda County</DIV>
<DIV><FONT size=2 face=Arial></FONT><BR></DIV>
<DIV class=WordSection1>
<P><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt">Thanks
to one of our members for the attached 11-page complaint filed in
federal court by PhRMA, GPhA, and BIO against Alameda County's Safe Drug
Disposal Ordinance. The lawsuit provides a concise summary of the law. It
is also a broad rebuttal against the concept of producer responsibility,
arguing that drug-take back programs should be a government function.
<o:p></o:p></SPAN></P>
<P><SPAN
style="FONT-FAMILY: 'Calibri','sans-serif'; COLOR: black; FONT-SIZE: 11pt"><o:p> </o:p></SPAN></P>
<DIV>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: Consolas; COLOR: #1f497d; FONT-SIZE: 10.5pt"><o:p> </o:p></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: navy; FONT-SIZE: 10pt">____________________________</SPAN><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt"><BR><B>Scott
Cassel<o:p></o:p></B></SPAN></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt">Chief<B>
</B></SPAN><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt">Executive
Officer/Founder<BR><I>Product Stewardship Institute, Inc.</I><BR>29 Stanhope
Street<BR>Boston, MA 02116<BR>617-236-4822 (ph)<BR>617-236-4766 (fax)
<BR></SPAN><SPAN style="COLOR: black"><A
href="mailto:scott@productstewardship.us"><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: blue; FONT-SIZE: 10pt">scott@productstewardship.us</SPAN></A><BR><A
href="http://www.productstewardship.us/"><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: blue; FONT-SIZE: 10pt">www.productstewardship.us</SPAN></A></SPAN><B><SPAN
style="FONT-FAMILY: 'Arial','sans-serif'; COLOR: black; FONT-SIZE: 10pt"><o:p></o:p></SPAN></B></P>
<P class=MsoNormal><SPAN
style="FONT-FAMILY: Webdings; COLOR: green; FONT-SIZE: 18pt" lang=EN-GB>P
</SPAN><SPAN style="FONT-FAMILY: Courier; COLOR: #008040; FONT-SIZE: 10pt"
lang=EN-GB>Please consider the environment before printing this
email</SPAN><SPAN style="COLOR: black"><o:p></o:p></SPAN></P>
<P class=MsoNormal><B><SPAN style="COLOR: gray">Click to follow us on
</SPAN></B><SPAN style="COLOR: #1f497d"><A
href="http://www.facebook.com/pages/Product-Stewardship-Institute/224328115936?ref=ts"><B><SPAN
style="COLOR: #4f81bd">Facebook</SPAN></B></A></SPAN><B><SPAN
style="COLOR: gray"> and </SPAN></B><SPAN style="COLOR: #1f497d"><A
href="http://twitter.com/productsteward"><B><SPAN
style="COLOR: #4f81bd">Twitter</SPAN></B></A> </SPAN><B><SPAN
style="COLOR: gray">and</SPAN></B><SPAN style="COLOR: #1f497d">
</SPAN><B><SPAN style="COLOR: #4f81bd"><A
href="http://productstewardshipinstitute.wordpress.com/"><SPAN
style="COLOR: #4f81bd">Blog</SPAN></A></SPAN></B><SPAN
style="FONT-FAMILY: 'Tahoma','sans-serif'; COLOR: black; FONT-SIZE: 10pt">
<o:p></o:p></SPAN></P></DIV></DIV>
<P>
<HR>
<P></P>---<BR>Note: As a courtesy to other listserv subscribers, please post
messages to the listserv in plain text format to avoid the garbling of
messages received by digest recipients.<BR>---<BR>TO SUBSCRIBE, go
to:
http://lists.dep.state.fl.us/cgi-bin/mailman/listinfo/pharmwaste <BR>TO
UNSUBSCRIBE, DO NOT REPLY TO THE LISTSERV. Please send an e-mail to
pharmwaste-unsubscribe@lists.dep.state.fl.us -- the subject line and body of
the e-mail should be blank.<BR>If you believe you may be subscribed with a
different email address, please visit the subscriber listing at
http://lists.dep.state.fl.us/cgi-bin/mailman/roster/pharmwaste <BR>FOR
PROBLEMS: Contact List Administrator Laurie.Tenace@dep.state.fl.us
<BR>SEND MAIL to the list server at:
pharmwaste@lists.dep.state.fl.us<BR></BLOCKQUOTE></BODY></HTML>